Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

RPRX – Royalty Pharma plc

Royalty Pharma plc
RPRX
$35.87
Name : Royalty Pharma plc
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $20,167,548,928.00
EPSttm : 2.45
finviz dynamic chart for RPRX
Royalty Pharma plc
$35.87
1.70%
$0.6

Float Short %

8.74

Margin Of Safety %

34

Put/Call OI Ratio

0.17

EPS Next Q Diff

0.39

EPS Last/This Y

2.49

EPS This/Next Y

0.6

Price

35.87

Target Price

42.17

Analyst Recom

1.57

Performance Q

13.33

Relative Volume

0.7

Beta

0.49

Ticker: RPRX




19 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-06-02RPRX33.260.190.0129925
2025-06-03RPRX33.30.190.0530031
2025-06-04RPRX33.440.190.9430078
2025-06-05RPRX33.760.190.0130116
2025-06-06RPRX33.790.190.0230189
2025-06-09RPRX33.390.190.0030228
2025-06-10RPRX33.570.190.1830339
2025-06-11RPRX34.050.180.0230490
2025-06-12RPRX35.260.180.0630668
2025-06-13RPRX34.850.180.2331818
2025-06-16RPRX35.10.180.0131854
2025-06-17RPRX34.560.180.0831855
2025-06-18RPRX34.910.180.0031828
2025-06-20RPRX34.870.170.0034425
2025-06-23RPRX35.410.160.0831009
2025-06-24RPRX36.130.170.1031085
2025-06-25RPRX35.920.170.0331399
2025-06-26RPRX35.260.170.0931331
2025-06-27RPRX35.880.170.0631391
DateSymbolLastP/C OIP/C VolTotal OI
19 items Current Page1 of 1




19 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-06-02RPRX33.259.2218.34.42
2025-06-03RPRX33.299.2202.14.42
2025-06-04RPRX33.449.2218.44.42
2025-06-05RPRX33.759.2225.94.42
2025-06-06RPRX33.789.2212.04.42
2025-06-09RPRX33.399.2182.54.42
2025-06-10RPRX33.589.2209.74.42
2025-06-11RPRX34.059.2222.74.42
2025-06-12RPRX35.279.2257.34.42
2025-06-13RPRX34.849.2181.34.42
2025-06-16RPRX35.099.2212.14.42
2025-06-17RPRX34.559.2175.84.42
2025-06-18RPRX34.919.2216.84.42
2025-06-20RPRX34.869.2198.54.42
2025-06-23RPRX35.409.2225.14.42
2025-06-24RPRX36.139.2233.94.42
2025-06-25RPRX35.939.2191.44.42
2025-06-26RPRX35.269.2170.94.42
2025-06-27RPRX35.878.6227.84.41
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
19 items Current Page1 of 1




18 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-06-02RPRX0.00-0.246.24
2025-06-03RPRX0.00-0.246.24
2025-06-04RPRX0.00-0.246.24
2025-06-05RPRX0.00-0.246.24
2025-06-06RPRX0.00-0.246.24
2025-06-09RPRX0.00-0.166.24
2025-06-10RPRX0.00-0.166.24
2025-06-11RPRX0.00-0.168.73
2025-06-12RPRX0.00-0.168.73
2025-06-13RPRX0.00-0.168.73
2025-06-16RPRX0.001.948.73
2025-06-18RPRX0.001.948.73
2025-06-20RPRX0.001.948.73
2025-06-23RPRX0.00-0.178.73
2025-06-24RPRX0.00-0.178.73
2025-06-25RPRX0.00-0.178.73
2025-06-26RPRX0.00-0.178.74
2025-06-27RPRX0.00-0.178.74
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
18 items Current Page1 of 1

Last Quarter Act. EPS

0.65

Avg. EPS Est. Current Quarter

1.04

Avg. EPS Est. Next Quarter

1.04

Insider Transactions

Institutional Transactions

-0.17

Beta

0.49

Average Sales Estimate Current Quarter

725

Average Sales Estimate Next Quarter

771

Fair Value

48.05

Quality Score

73

Growth Score

83

Sentiment Score

80

Actual DrawDown %

32.6

Max Drawdown 5-Year %

-49.7

Target Price

42.17

P/E

14.63

Forward P/E

7.17

PEG

1.35

P/S

8.91

P/B

2.28

P/Free Cash Flow

7.32

EPS

2.45

Average EPS Est. Cur. Y​

4.41

EPS Next Y. (Est.)

5.01

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

48.24

Relative Volume

0.7

Return on Equity vs Sector %

-7.6

Return on Equity vs Industry %

10.3

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.01

EBIT Estimation

227.8
Royalty Pharma plc
Sector: Healthcare
Industry: Biotechnology
Employees:
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 14 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neuroscience, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
stock quote shares RPRX – Royalty Pharma plc Stock Price stock today
news today RPRX – Royalty Pharma plc stock forecast ,stock prediction 2023 2024 2025
marketwatch RPRX – Royalty Pharma plc yahoo finance google finance
stock history RPRX – Royalty Pharma plc invest stock market
stock prices RPRX premarket after hours
ticker RPRX fair value insiders trading